← Back to Search

CARE Program + Valera App Interventions for Parenting Challenges During Coronavirus (CARE Trial)

N/A
Recruiting
Led By Vilma Gabbay, MD
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Primary language other than Spanish or English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 24
Awards & highlights
No Placebo-Only Group

Summary

This trial tests the CARE program and Valera Health app to help stressed caregivers in the Bronx. The CARE program offers group sessions for emotional support, while the Valera Health app provides digital mental health resources. These interventions aim to reduce stress and improve mental health among caregivers.

Who is the study for?
This trial is for primary caregivers in the Bronx experiencing high stress, especially those working on-site at Montefiore Medical Center or patients in psychiatric and rheumatology clinics there. It includes grandmothers and aunts but excludes those with neurocognitive issues, serious psychiatric/substance use problems, active child abuse cases, non-Spanish/English speakers, or prior similar app users.
What is being tested?
The study tests various combinations of the CARE Program and Valera Application to alleviate parental stress due to COVID-19. Some will use both tools with added care manager support; others will try each tool separately or combined without extra support.
What are the potential side effects?
Since this trial involves psychological interventions rather than medications, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing personal challenges related to parenting during the pandemic.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My primary language is not English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 24 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Perceived Stress
Secondary study objectives
Beck Anxiety Index
Beck Depression Index
Beck Suicide Scale Inventory
+5 more
Other study objectives
Alcohol Use Disorders Identification Test (Audit C)
COVID Impact Scale
Drug Abuse Screening Test
+15 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Parents of children receiving mental health treatment at MontefioreExperimental Treatment3 Interventions
Participants will either CARE program alone; b) Valera Health app; c) CARE program and Valera Health app .
Group II: Parents of children being treated for autoimmune disorders at MontefioreExperimental Treatment3 Interventions
Participants will either CARE program alone; b) Valera Health app; c) CARE program and Valera Health app.
Group III: Healthcare workers at MontefioreExperimental Treatment3 Interventions
Participants will either CARE program alone; b) Valera Health app; c) CARE program and Valera Health app.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The multimodal parent-focused intervention includes strategies such as psychological support, financial assistance, and telehealth services. Psychological support mechanisms often involve cognitive-behavioral therapy (CBT) to help parents manage stress, anxiety, and depression by changing negative thought patterns and behaviors. Financial assistance aims to alleviate economic stressors that can exacerbate mental health issues. Telehealth services provide accessible healthcare options, reducing barriers to receiving timely support. These mechanisms are crucial for parenting patients as they help mitigate the psychological and health impacts of the pandemic, enabling parents to provide better care and support for their children, thereby breaking potential cycles of stress and trauma.
Diagnosis and management of trichotillomania in children and adolescents.

Find a Location

Who is running the clinical trial?

Albert Einstein College of MedicineLead Sponsor
296 Previous Clinical Trials
11,688,657 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,913 Previous Clinical Trials
2,738,175 Total Patients Enrolled
7 Trials studying Parenting
760 Patients Enrolled for Parenting
Vilma Gabbay, MDPrincipal InvestigatorAlbert Einstein College of Medicine
2 Previous Clinical Trials
560 Total Patients Enrolled

Media Library

CARE Program Clinical Trial Eligibility Overview. Trial Name: NCT04991467 — N/A
Parenting Research Study Groups: Parents of children receiving mental health treatment at Montefiore, Parents of children being treated for autoimmune disorders at Montefiore, Healthcare workers at Montefiore
Parenting Clinical Trial 2023: CARE Program Highlights & Side Effects. Trial Name: NCT04991467 — N/A
CARE Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04991467 — N/A
~108 spots leftby Mar 2026